Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Cass

Showing results (161-170 of 289) with videos related to

Pageof 29
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 20, 2015
Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKDRachael L Morton, Iryna Schlackow, Natalie Staplin, et al.
Journal of the American College of Cardiology|September 11, 2010
Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trialMeg J Jardine, Toshiharu Ninomiya, Vlado Perkovic, et al.
BMC Nephrology|April 19, 2021
Effectiveness of Wellbeing Intervention for Chronic Kidney Disease (WICKD): results of a randomised controlled trialKylie M Dingwall, Michelle Sweet, Alan Cass, et al.
International Journal of Environmental Research and Public Health|July 2, 2021
What Matters 2 Adults (WM2Adults): Understanding the Foundations of Aboriginal and Torres Strait Islander WellbeingGail Garvey, Kate Anderson, Alana Gall, et al.
BMC Nephrology|May 1, 2015
What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?Seamus Kent, Iryna Schlackow, Jingky Lozano-Kühne, et al.
The Cochrane Database of Systematic Reviews|September 25, 2018
Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney diseaseClement Lo, Tadashi Toyama, Ying Wang, et al.
The Medical Journal of Australia|July 2, 2015
Facilitators and barriers to implementation of a pragmatic clinical trial in Aboriginal health servicesHueming Liu, Tracey-Lea Laba, Luciana Massi, et al.
Kidney International Reports|June 2, 2018
Impact of CKD on Household IncomeRachael L Morton, Iryna Schlackow, Alastair Gray, et al.
The Cochrane Database of Systematic Reviews|June 1, 2016
Interventions for lowering plasma homocysteine levels in dialysis patientsSagar U Nigwekar, Amy Kang, Sophia Zoungas, et al.
Nephrology (Carlton, Vic.)|December 23, 2014
Design and participant baseline characteristics of 'A Clinical Trial of IntensiVE Dialysis': the ACTIVE Dialysis StudyMeg J Jardine, L I Zuo, Nicholas A Gray, et al.
Pageof 29

Showing results (161-170 of 289) with videos related to

Sort By:
Pageof 29
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 20, 2015
Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKDRachael L Morton, Iryna Schlackow, Natalie Staplin, et al.
Journal of the American College of Cardiology|September 11, 2010
Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trialMeg J Jardine, Toshiharu Ninomiya, Vlado Perkovic, et al.
BMC Nephrology|April 19, 2021
Effectiveness of Wellbeing Intervention for Chronic Kidney Disease (WICKD): results of a randomised controlled trialKylie M Dingwall, Michelle Sweet, Alan Cass, et al.
International Journal of Environmental Research and Public Health|July 2, 2021
What Matters 2 Adults (WM2Adults): Understanding the Foundations of Aboriginal and Torres Strait Islander WellbeingGail Garvey, Kate Anderson, Alana Gall, et al.
BMC Nephrology|May 1, 2015
What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?Seamus Kent, Iryna Schlackow, Jingky Lozano-Kühne, et al.
The Cochrane Database of Systematic Reviews|September 25, 2018
Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney diseaseClement Lo, Tadashi Toyama, Ying Wang, et al.
The Medical Journal of Australia|July 2, 2015
Facilitators and barriers to implementation of a pragmatic clinical trial in Aboriginal health servicesHueming Liu, Tracey-Lea Laba, Luciana Massi, et al.
Kidney International Reports|June 2, 2018
Impact of CKD on Household IncomeRachael L Morton, Iryna Schlackow, Alastair Gray, et al.
The Cochrane Database of Systematic Reviews|June 1, 2016
Interventions for lowering plasma homocysteine levels in dialysis patientsSagar U Nigwekar, Amy Kang, Sophia Zoungas, et al.
Nephrology (Carlton, Vic.)|December 23, 2014
Design and participant baseline characteristics of 'A Clinical Trial of IntensiVE Dialysis': the ACTIVE Dialysis StudyMeg J Jardine, L I Zuo, Nicholas A Gray, et al.
Pageof 29